A novel model-based approach for dose determination of glycopyrronium bromide in COPD

by Arievich Helen, Overend Tim, Renard Didier, Gibbs Michael, Alagappan Vijay, Looby Michael, Banerji Donald
Published 2012-12-01

Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial

by D'Urzo Anthony, Ferguson Gary T, van Noord Jan A, Hirata Kazuto, Martin Carmen, Horton Rachael, Lu Yimeng, Banerji Donald, Overend Tim
Published 2011-12-01